Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabotegravir PK in Hepatic Impairment
NCT02354950Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jun 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of cabotegravir in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Jun 2015; status: completed.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02354950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354950.